Long-term clinical outcomes following sirolimus-eluting stent implantation in patients with acute myocardial infarction. A meta-analysis of randomized trials

Clinical Research in Cardiology

Volumn 101, Issue 11, 2012, Pages 885-893

  Piccolo, Raffaele ^a   Cassese, Salvatore ^a   Galasso, Gennaro ^a   Niglio, Tullio ^a   De Rosa, Roberta ^a   De Biase, Chiara ^a   Piscione, Federico ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

Acute myocardial infarction; Bare metal stent; Drug eluting stent; Meta analysis; Primary PCI

Indexed keywords

RAPAMYCIN;

ARTICLE; BARE METAL STENT; CLINICAL EFFECTIVENESS; DRUG ELUTING STENT; HEART MUSCLE REVASCULARIZATION; HEART REINFARCTION; HUMAN; INTERMETHOD COMPARISON; META ANALYSIS; OUTCOME ASSESSMENT; PATIENT SAFETY; PERCUTANEOUS CORONARY INTERVENTION; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK REDUCTION; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; STENT THROMBOSIS;

CARDIOVASCULAR AGENTS; CHI-SQUARE DISTRIBUTION; CORONARY THROMBOSIS; DRUG-ELUTING STENTS; HUMANS; MIDDLE AGED; MYOCARDIAL INFARCTION; ODDS RATIO; PERCUTANEOUS CORONARY INTERVENTION; PROSTHESIS DESIGN; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RECURRENCE; RISK ASSESSMENT; RISK FACTORS; SIROLIMUS; TIME FACTORS; TREATMENT OUTCOME;

EID: 84869128663     PISSN: 18610684     EISSN: 18610692     Source Type: Journal    
DOI: 10.1007/s00392-012-0472-y     Document Type: Article

References (37)

1. Keeley EC, Boura JA, Grines CL (2003) Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: A quantitative review of 23 randomised trials. Lancet 361(9351):13-20
2. Piscione F, Piccolo R, Cassese S, Galasso G, Chiariello M (2009) Clinical impact of sirolimus-eluting stent in ST-segment elevation myocardial infarction: A meta-analysis of randomized clinical trials. Catheter Cardiovasc Interv 74(2):323-332
3. Steg PG, Fox KA, Eagle KA, Furman M, Van de Werf F, Montalescot G, Goodman SG, Avezum A, Huang W, Gore JM (2009) Mortality following placement of drug-eluting and baremetal stents for ST-segment elevation acute myocardial infarction in the Global Registry of Acute Coronary Events. Eur Heart J 30(3):321-329
4. Kukreja N, Onuma Y, Garcia-Garcia HM, Daemen J, van Domburg R, Serruys PW (2009) The risk of stent thrombosis in patients with acute coronary syndromes treated with bare-metal and drug-eluting stents. Jacc 2(6):534-541
5. Piccolo R, Cassese S, Galasso G, De Rosa R, D'Anna C, Piscione F (2011) Long-term safety and efficacy of drug-eluting stents in patients with acute myocardial infarction: A meta-analysis of randomized trials. Atherosclerosis 217(1):149-157
6. Piccolo R, Cassese S, Galasso G, De Rosa R, D'Anna C, Piscione F (2011) Sirolimus-versus paclitaxel-eluting stents in patients with acute myocardial infarction: A meta-analysis of randomized trials. Int J Cardiol 146(2):234-236
7. Piscione F, Piccolo R, Cassese S, Galasso G, De Rosa R, D'Andrea C, Chiariello M (2010) Effect of drug-eluting stents in patients with acute ST-segment elevation myocardial infarction undergoing percutaneous coronary intervention: A meta-analysis of randomised trials and an adjusted indirect comparison. Euro-Intervention 5(7):853-860
8. Higgins JP (2008) Green Se Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.2 (updated September 2009). The Cochrane Collaboration. http://www.cochrane -handbook.org
9. Juni P, Witschi A, Bloch R, Egger M (1999) The hazards of scoring the quality of clinical trials for meta-analysis. JAMA 282(11):1054-1060
10. Cutlip DE, Windecker S, Mehran R, Boam A, Cohen DJ, van Es GA, Steg PG, Morel MA, Mauri L, Vranckx P, McFadden E, Lansky A, Hamon M, Krucoff MW, Serruys PW (2007) Clinical end points in coronary stent trials: A case for standardized definitions. Circulation 115(17):2344-2351
11. Higgins JP, Thompson SG, Deeks JJ, Altman DG (2003) Measuring inconsistency in meta-analyses. BMJ (Clinical research ed) 327(7414):557-560
12. Harbord RM, Egger M, Sterne JA (2006) A modified test for small-study effects in meta-analyses of controlled trials with binary endpoints. Stat Med 25(20):3443-3457
13. Peters JL, Sutton AJ, Jones DR, Abrams KR, Rushton L (2006) Comparison of two methods to detect publication bias in metaanalysis. JAMA 295(6):676-680
14. Moher D, Liberati A, Tetzlaff J, Altman DG (2009) Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement. Ann Intern Med 151(4):264-269 W264
15. Leibundgut G, Nietlispach F, Pittl U, Brunner-La Rocca H, Kaiser CA, Pfisterer ME (2009) Stent thrombosis up to 3 years after stenting for ST-segment elevation myocardial infarction versus for stable angina -comparison of the effects of drugeluting versus bare-metal stents. Am Heart J 158(2):271-276
16. Atary JZ, van der Hoeven BL, Liem SS, Jukema JW, van der Bom JG, Atsma DE, Bootsma M, Zeppenfeld K, van der Wall EE, Schalij MJ (2010) Three-year outcome of sirolimus-eluting versus bare-metal stents for the treatment of ST-segment elevation myocardial infarction (from the MISSION! Intervention Study). Am J Cardiol 106(1):4-12
17. Valgimigli M, Campo G, Gambetti S, Bolognese L, Ribichini F, Colangelo S, de Cesare N, Rodriguez AE, Russo F, Moreno R, Piva T, Sheiban I, Penzo C, Prati F, Nazzaro MS, Diaz Fernandez JF, Vassanelli C, Parrinello G, Ferrari R (2011) Three-year follow-up of the MULTIcentre evaluation of single high-dose bolus TiRofiban versus abciximab with sirolimus-eluting STEnt or bare-metal stent in acute myocardial infarction StudY (MULTISTRATEGY). Int J Cardiol. [Epub ahead of print]
18. Di Lorenzo E, Sauro R, Varricchio A, Carbone G, Cortese G, Capasso M, Lanzillo T, Manganelli F, Mariello C, Siano F, Pagliuca MR, Stanco G, Rosato G, De Luca G (2009) Long-Term outcome of drug-eluting stents compared with bare metal stents in ST-segment elevation myocardial infarction: Results of the paclitaxel-or sirolimus-eluting stent versus bare metal stent in Primary Angioplasty (PASEO) Randomized Trial. Circulation 120(11):964-972
19. Violini R, Musto C, De Felice F, Nazzaro MS, Cifarelli A, Petitti T, Fiorilli R (2010) Maintenance of long-term clinical benefit with sirolimus-eluting stents in patients with ST-segment elevation myocardial infarction: 3-year results of the SESAMI (sirolimus-eluting stent versus bare-metal stent in acute myocardial infarction) trial. J Am Coll Cardiol 55(8):810-814
20. Tebaldi M, Arcozzi C, Campo G, Percoco G, Ferrari R, Valgimigli M (2009) The 5-year clinical outcomes after a randomized comparison of sirolimus-eluting versus bare-metal stent implantation in patients with ST-segment elevation myocardial infarction. J Am Coll Cardiol 54(20):1900-1901
21. Spaulding C, Teiger E, Commeau P, Varenne O, Bramucci E, Slama M, Beatt K, Tirouvanziam A, Polonski L, Stella PR, Clugston R, Fajadet J, de Boisgelin X, Bode C, Carrie D, Erglis A, Merkely B, Hosten S, Cebrian A, Wang P, Stoll HP, Henry P (2011) Four-year follow-up of TYPHOON (trial to assess the use of the CYPHer sirolimus-eluting coronary stent in acute myocardial infarction treated with BallOON angioplasty). Jacc 4(1):14-23
22. Simsek C, Magro M, Boersma E, Onuma Y, Nauta S, Daemen J, Gaspersz M, van Geuns RJ, van der Giessen W, van Domburg R, Serruys P (2011) Comparison of six-year clinical outcome of sirolimus-and paclitaxel-eluting stents to bare-metal stents in patients with ST-segment elevation myocardial infarction: An analysis of the RESEARCH (rapamycin-eluting stent evaluated at Rotterdam cardiology hospital) and T-SEARCH (taxus stent evaluated at Rotterdam cardiology hospital) registries. J Invasive Cardiol 23(8):336-341
23. Jensen LO, Maeng M, Thayssen P, Kaltoft A, Tilsted HH, Bottcher M, Lassen JF, Hansen KN, Krusell LR, Rasmussen K, Pedersen KE, Pedersen L, Paaske Johnsen S, Sorensen HT, Thuesen L (2008) Clinical outcome after primary percutaneous coronary intervention with drug-eluting and bare metal stents in patients with ST-segment elevation myocardial infarction. Circ Cardiovasc Interv 1(3):176-184
24. Mauri L, Silbaugh TS, Garg P, Wolf RE, Zelevinsky K, Lovett A, Varma MR, Zhou Z, Normand SL (2008) Drug-eluting or baremetal stents for acute myocardial infarction. New Engl J Med 359(13):1330-1342
25. Dibra A, Tiroch K, Schulz S, Kelbaek H, Spaulding C, Laarman GJ, Valgimigli M, Di Lorenzo E, Kaiser C, Tierala I, Mehilli J, Campo G, Thuesen L, Vink MA, Schalij MJ, Violini R, Schomig A, Kastrati A (2010) Drug-eluting stents in acute myocardial infarction: Updated meta-analysis of randomized trials. Clin Res Cardiol 99(6):345-357
26. Kastrati A, Mehilli J, Pache J, Kaiser C, Valgimigli M, Kelbaek H, Menichelli M, Sabate M, Suttorp MJ, Baumgart D, Seyfarth M, Pfisterer ME, Schomig A (2007) Analysis of 14 trials comparing sirolimus-eluting stents with bare-metal stents. New Engl J Med 356(10):1030-1039
27. Wenaweser P, Daemen J, Zwahlen M, van Domburg R, Juni P, Vaina S, Hellige G, Tsuchida K, Morger C, Boersma E, Kukreja N, Meier B, Serruys PW, Windecker S (2008) Incidence and correlates of drug-eluting stent thrombosis in routine clinical practice. 4-year results from a large 2-institutional cohort study. J Am Coll Cardiol 52(14):1134-1140
28. Brodie B, Pokharel Y, Fleishman N, Bensimhon A, Kissling G, Hansen C, Milks S, Cooper M, McAlhany C, Stuckey T (2011) Very late stent thrombosis after primary percutaneous coronary intervention with bare-metal and drug-eluting stents for ST-segment elevation myocardial infarction: A 15-year single-center experience. Jacc 4(1):30-38
29. Nakazawa G, Finn AV, Joner M, Ladich E, Kutys R, Mont EK, Gold HK, Burke AP, Kolodgie FD, Virmani R (2008) Delayed arterial healing and increased late stent thrombosis at culprit sites after drug-eluting stent placement for acute myocardial infarction patients: An autopsy study. Circulation 118(11):1138-1145
30. Fujii K, Carlier SG, Mintz GS, Yang YM, Moussa I, Weisz G, Dangas G, Mehran R, Lansky AJ, Kreps EM, Collins M, Stone GW, Moses JW, Leon MB (2005) Stent underexpansion and residual reference segment stenosis are related to stent thrombosis after sirolimus-eluting stent implantation: An intravascular ultrasound study. J Am Coll Cardiol 45(7):995-998
31. Lee CW, Kang SJ, Park DW, Lee SH, Kim YH, Kim JJ, Park SW, Mintz GS, Park SJ (2010) Intravascular ultrasound findings in patients with very late stent thrombosis after either drugeluting or bare-metal stent implantation. J Am Coll Cardiol 55(18):1936-1942
32. Hassan AK, Bergheanu SC, Stijnen T, van der Hoeven BL, Snoep JD, Plevier JW, Schalij MJ, Wouter Jukema J (2010) Late stent malapposition risk is higher after drug-eluting stent compared with bare-metal stent implantation and associates with late stent thrombosis. Eur Heart J 31(10):1172-1180
33. Shishehbor MH, Amini R, Oliveria LP, Singh IM, Kelly P, Bhatt DL, Kapadia SR, Ellis SG, Whitlow PL, Brener SJ (2008) Comparison of drug-eluting stents versus bare-metal stents for treating ST-segment elevation myocardial infarction. Jacc 1(3):227-232
34. Brodie BR, Stuckey T, Downey W, Humphrey A, Nussbaum M, Laurent S, Bradshaw B, Metzger C, Hermiller J, Krainin F, Juk S, Cheek B, Duffy P, Simonton CA (2008) Outcomes with drugeluting stents versus bare metal stents in acute ST-elevation myocardial infarction: Results from the Strategic Transcatheter Evaluation of New Therapies (STENT) Group. Catheter Cardiovasc Interv 72(7):893-900
35. Stone GW, Parise H, Witzenbichler B, Kirtane A, Guagliumi G, Peruga JZ, Brodie BR, Dudek D, Mockel M, Lansky AJ, Mehran R (2010) Selection criteria for drug-eluting versus bare-metal stents and the impact of routine angiographic follow-up: 2-year insights from the HORIZONS-AMI (Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction) trial. J Am Coll Cardiol 56(19):1597-1604
36. Cassese S, Piccolo R, Galasso G, De Rosa R, Piscione F (2011) Twelve-month clinical outcomes of everolimus-eluting stent as compared to paclitaxel-and sirolimus-eluting stent in patients undergoing percutaneous coronary interventions. A meta-analysis of randomized clinical trials. Int J Cardiol 150(1):84-89
37. de Waha A, Cassese S, Park DW, Burzotta F, Byrne RA, Tada T, King LA, Park SJ, Schomig A, Kastrati A (2012) Everolimuseluting versus sirolimus-eluting stents: An updated meta-analysis of randomized trials. Clin Res Cardiol. [Epub ahead of print]